Does Dr. LINDSEY ADDINGTON have financial conflicts of interest?

Dr. LINDSEY ADDINGTON (NP) has received a total of $794 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $794 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. LINDSEY ADDINGTON?

According to CMS Open Payments data, Dr. LINDSEY ADDINGTON received funding from ADAPTIVE BIOTECHNOLOGIES CORPORATION ($305), MERCK SHARP & DOHME ($214), and AVEO PHARMACEUTICALS ($99).

Does Dr. LINDSEY ADDINGTON receive research grants or speaking fees?

Dr. LINDSEY ADDINGTON has received $794 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. LINDSEY ADDINGTON

NPReal-Time Hydrated

Specialty: Nurse Practitioner, Gerontology

Practice Location: INDIANAPOLIS, IN 46250

NPI Number: 1083029474

LIFETIME INDUSTRY VALUE

$794

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ADDINGTON is a verified Nurse Practitioner, Gerontology practitioner based in INDIANAPOLIS, IN.

Between 2021 and 2025, Dr. ADDINGTON had an overall industry promotional and research financial footprint of $794 as recorded in the federal CMS Open Payments database.

$794 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADDINGTON's primary funding source is ADAPTIVE BIOTECHNOLOGIES CORPORATION, which accounts for $305 (representing 38.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ADAPTIVE BIOTECHNOLOGIES CORPORATION

Rank 1

$305

38.4%

MERCK SHARP & DOHME

Rank 2

$214

27%

AVEO PHARMACEUTICALS

Rank 3

$99

12.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.